Abbott LaboratoriesABTNYSE
Loading
Interest Expense Over TimeContracting
Percentile Rank36
3Y CAGR+2.7%
5Y CAGR-13.6%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+2.7%/yr
vs -18.9%/yr prior
5Y CAGR
-13.6%/yr
Recent acceleration
Acceleration
+21.6pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $341.00M | -43.4% |
| 2024 | $603.00M | -13.6% |
| 2023 | $698.00M | +121.6% |
| 2022 | $315.00M | -23.2% |
| 2021 | $410.00M | -42.1% |
| 2020 | $708.00M | -13.4% |
| 2019 | $818.00M | +12.2% |
| 2018 | $729.00M | -17.2% |
| 2017 | $880.00M | +189.5% |
| 2016 | $304.00M | - |